MAITREYA
Maitreya Medicare financials
- Market cap
- ₹79 Cr
- Sector
- Healthcare
What Maitreya Medicare Ltd does
Maitreya Medicare runs a flagship multi-super-speciality hospital in Surat, Gujarat, established in 2019, offering primary, secondary and tertiary care across 18+ specialties including cardiology, oncology, neurosurgery, nephrology (with dialysis) and orthopedics. It has grown through subsidiaries and partner-operated hospitals - Tulip Health Check (elderly/geriatric and diagnostic care), Maitreya Hospital Pvt Ltd at Valsad, Maitreya Life Science (cardiology/cathlab services at KP Sanghavi Trust Hospital), and management-services tie-ups with KLS Memorial Hospital (Mumbai) and Prannath Hospital (Surat). It earns revenue from inpatient and outpatient hospital services delivered through these owned, subsidiary and partner facilities.
Segments
- Hospital services (Maitreya Medicare Ltd, flagship)
- Tulip Health Check
- Maitreya Hospital Private Limited
- Maitreya Life Science Pvt Ltd
- KLS Memorial Hospital (operational partner)
- Prannath Hospital (partner)
- Aggregate bed capacity
- 550 beds
- Hospital locations
- Surat, Valsad, Mumbai, Nandurbar (Maharashtra)
- Flagship hospital bed capacity (Surat)
- 125 beds
- Maitreya Hospital Pvt Ltd, Valsad
- 125 beds; 3 modular OTs, 20-bed ICU, 6-bed dialysis unit
- Prannath Hospital, Surat (partner)
- 100 beds
- KLS Memorial Hospital, Mumbai (partner)
- 70 beds
Quarterly results
Q4 FY26: revenue down 8.1%, net profit down 2800.0% against the same quarter last year.
| Line item | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 25 | 23 | 24 | 22 | 24 −4% | 21 −8% |
| EBITDA | 5 | 1 | 3 | 2 | 1 −77% | -1 −228% |
| Net profit | 3 | 0 | 2 | 0 | -0 −102% | -2 −2800% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −52.5% 1Y
1Y: ₹244.3 on 10 Sept 2025 → ₹116. High ₹288.65 (13 Nov 2025), low ₹110.5 (18 Aug 2026).
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹7 Cr | ₹12 Cr | ₹12 Cr |
| Reserves | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹18 Cr | ₹20 Cr | ₹17 Cr |
| Borrowings | ₹14 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹4 Cr | ₹23 Cr |
| Other liabilities | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹8 Cr | ₹13 Cr | ₹16 Cr |
| Total liabilities | ₹25 Cr | ₹24 Cr | ₹29 Cr | ₹44 Cr | ₹49 Cr | ₹68 Cr |
| Fixed assets | ₹14 Cr | ₹13 Cr | ₹12 Cr | ₹14 Cr | ₹16 Cr | ₹41 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹10 Cr | ₹11 Cr | ₹17 Cr | ₹28 Cr | ₹33 Cr | ₹28 Cr |
| Total assets | ₹25 Cr | ₹24 Cr | ₹29 Cr | ₹44 Cr | ₹49 Cr | ₹68 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
The ownership split has held steady since Mar 2025. The shareholder count shrank 1% to 976.
- Promoters
- 73.1%
- Public
- 26.9%
Since Mar 2025
- FIIs −0.01 pp
- Public +0.01 pp
- Promoters 0.00 pp
How it drifted, 5 quarters
Over this window the public went from 23.0% to 26.9% — +3.9 pp.
Ownership split by quarter, oldest first. Mar '24: Promoters 73.1%, FIIs 2.5%, DIIs 1.4%, Public 23.0%.Sep '24: Promoters 73.1%, FIIs 0.4%, Public 26.5%.Mar '25: Promoters 73.1%, FIIs 0.0%, Public 26.9%.Sep '25: Promoters 73.0%, Public 27.0%.Mar '26: Promoters 73.1%, Public 26.9%.
Who bought this quarter
since Sep 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Vimalkumar Natverlal Patel +0.43 pp 10.43% held
The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of Maitreya Medicare Ltd above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| Narendra Singh Tanwar | 47.02% | unchanged |
| Pranav Rohitbhai Thaker | 15.66% | −0.34 pp |
| Vimalkumar Natverlal Patel | 10.43% | +0.43 pp |
| South Gujarat Shares And Sharebrokers Limited | 2.76% | −0.24 pp |
| Hashim Yacoobali | 1.02% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Maitreya Medicare Ltd
Guides on how to read this kind of business and the numbers that matter.